| Combination of entecavir with thymosin alpha-1 in HBV-related compensated cirrhosis: a prospective multicenter randomized open-label study | |
| Wu, Xiaoning; Shi, Yiwen; Zhou, Jialing; Sun, Yameng; Piao, Hongxin; Jiang, Wei; Ma, Anlin; Chen, Yongpeng; Xu, Mingyi; Xie, Wen | |
| 刊名 | EXPERT OPINION ON BIOLOGICAL THERAPY
 |
| 2018 | |
| 卷号 | 18 |
| 关键词 | Hepatitis B virus liver cirrhosis hepatocellular carcinoma immune regulator thymosin alpha-1 Ta-1 |
| ISSN号 | 1471-2598 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3605355 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Wu, Xiaoning,Shi, Yiwen,Zhou, Jialing,et al. Combination of entecavir with thymosin alpha-1 in HBV-related compensated cirrhosis: a prospective multicenter randomized open-label study[J]. EXPERT OPINION ON BIOLOGICAL THERAPY,2018,18. |
| APA | Wu, Xiaoning.,Shi, Yiwen.,Zhou, Jialing.,Sun, Yameng.,Piao, Hongxin.,...&You, Hong.(2018).Combination of entecavir with thymosin alpha-1 in HBV-related compensated cirrhosis: a prospective multicenter randomized open-label study.EXPERT OPINION ON BIOLOGICAL THERAPY,18. |
| MLA | Wu, Xiaoning,et al."Combination of entecavir with thymosin alpha-1 in HBV-related compensated cirrhosis: a prospective multicenter randomized open-label study".EXPERT OPINION ON BIOLOGICAL THERAPY 18(2018). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论